Nano Well-being Health, Inc., has issued a voluntary recall for Super Arthgold (500 mg) . Super Arthgold is a dietary supplement marketed for joint pain and arthritis. The U.S. Food and Drug Administration (FDA) has found that it contained undeclared drug ingredients, making it an unapproved new drug.
The ingredients that have been found in this supplement, but are not listed on the label are two prescription NSAIDs indomethacin, and diclofenac. The muscle relaxant chlorzoxazone was also found in these supplements.
According to a press release issued by the FDA:
“Use of this product containing undeclared drug ingredients has a reasonable probability of resulting in fatal adverse events in consumers and patients with underlying illnesses, including known allergy to the hidden ingredients, cardiac, gastrointestinal, hepatic [liver], and renal [kidney] conditions as well as patients who recently [have] undergone cardiac bypass graft surgery.”
Before taking any supplement it’s always a good idea to consult your physician. In this case, because the drugs were not listed on the label, there is risk of accidental overdose or higher risk of adverse side effects for those already taking NSAIDs.
As of December 18, 2009 all lots of Tylenol Arthritis Pain Caplets 100 count bottles with the red EZ Open Cap have been recalled. This recall has been expanded from an earlier recall of 5 lots of Tylenol Arthritis Pain Caplets in November, 2009. The caplets were recalled after consumer complaints that there was an unusual moldy, musty or mildew-like odor that was associated with nausea, vomiting, stomach pain and diarrhea. As a precautionary measure, all lots of Tylenol Arthritis Pain Caplets 100 with the red EZ OpenCap have been recalled.
Per the press release from the U.S. Food and Drug Administration (FDA) and McNeil Consumer Healthcare:
The recall is being expanded, as a precaution, to include all TYLENOL® Arthritis Pain Caplet 100 count bottles with the distinctive red EZ-OPEN CAP.
The uncharacteristic smell is caused by the presence of trace amounts of a chemical called 2,4,6-tribromoanisole. The source of 2,4,6-tribromoanisole is believed to be the breakdown of a chemical used to treat wooden pallets that transport and store packaging materials.The health effects of this compound have not been well studied, and to date all of the observed events reported to McNeil were temporary and non-serious. Consumers who purchased TYLENOL® Arthritis Pain Caplet 100 count bottles with the distinctive red EZ-OPEN CAP from the lots included in this recall should stop using the product and contact McNeil for instructions on a refund or replacement. For these instructions or information regarding how to return or dispose of the product, consumers should call 1-888-222-6036 1-888-222-6036 1-888-222-6036 (Monday-Friday 8 a.m. to 8 p.m. Eastern Time, and Saturday-Sunday 9 a.m. to 5 p.m. Eastern Time) or log on to the internet at www.tylenol.com.Consumers who have medical concerns or questions should contact their healthcare provider. Any adverse reactions may also be reported to the FDA’s MedWatch Program by fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov/medwatch.
For a complete list of all lots of Tylenol Arthritis Pain Caplets 100 recalled click HERE